News | May 23, 2026
Gujarat Themis Biosyn acquires MicroBiopharm Japan for Rs. 1,300 Cr
Transition to a fermentation-based globally integrated CDMO platform
Transition to a fermentation-based globally integrated CDMO platform
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
The company operates a chain of mid-sized multi-speciality hospitals
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The inspection concluded with 6 observations and none of them were related to Data Integrity
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
Alankit will undertake the verification of pending e-KYC enrollments through the Beneficiary Identification System (BIS) platform provided by the National Health Authority (NHA).
This facility marks a significant milestone in transforming the global food industr
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
